Abstract Details

Title The Efficacy of Cladribine in Relapsing-Remitting Multiple Sclerosis: Clinical Data from a Randomized, Double-Blind, Placebo-Controlled, 18-Month, Phase II Trial

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 160

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jack C. Sipe, MD, FAAN	No disclosure on file
Erica McKenzie, MD (University of Calgary, Department of Clinical Neurosciences)	Dr. McKenzie has nothing to disclose.
Jason Gardner, PhD (Smith Kline Beechman)	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��